Leidos Biomedical Research Inc
Leidos Biomedical Research Inc received $779.4M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 39.3% from $559.6M the year before, and $4.4B since FY2022. Its largest customer is the Department of Health and Human Services.
See 6 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- HV8BH9BPG8Y9
- CAGE code
- 3LYK6
- Headquarters
- Frederick, MD
- Business size
- Other Than Small Business
- Parent company
- Leidos Holdings, Inc. (UEI ZL41ERXMPAR3)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $779.4M | $4.4B |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AN12 | Health R&D services; Health Care services; Applied Research | $3.2B |
| M1HA | Operation of Government-Owned Contractor-Operated (Goco) R&D Facilities | $1.2B |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75N91025F00014 | Department of Health and Human Services NIAID VRC FY26-27 OPERATIONAL TASK ORDER | $87.8M | Aug 30, 2027 |
| 75N91025F00016 | Department of Health and Human Services NCI OPERATIONAL TASK ORDER, FY26-FY27 | $826.0M | Aug 30, 2027 |
| 75N91020F00030 | Department of Health and Human Services CPTAC BIOSPECIMEN COLLECTION | $21.9M | Aug 30, 2027 |
| 75N91022F00019 | Department of Health and Human Services DISCOVERY AND DEVELOPMENT OF CANCER THERAPEUTICS FOR NEXT PROGRAM | $22.4M | Sep 8, 2027 |
| 75N91021F00015 | Department of Health and Human Services CORE SUPPORT FOR THE IMMUNE CELL NETWORK | $20.9M | Dec 31, 2027 |
| 75N91021F00013 | Department of Health and Human Services ENABLING NCI CLINICAL & RESEARCH DATA SHARING | $83.6M | Feb 28, 2028 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75N91026F00034 | Department of Health and Human Services FUNCTIONAL PRECISION MEDICINE AND RESPONSE ASSAYS | $72.2M | Sep 29, 2026 |
| 75N91026F00033 | Department of Health and Human Services PALM004: AN OBSERVATIONAL STUDY OF THE NATURAL HISTORY OF BUNDIBUGYO VIRUS DISEASE | $11.7M | Sep 25, 2026 |
| 75N91026F00032 | Department of Health and Human Services CLINICAL MATERIAL TECHNOLOGY DEVELOPMENT AND PILOT MANUFACTURING | $17.7M | Sep 24, 2026 |
| 75N91026F00026 | Department of Health and Human Services INTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATES | $1.7M | Sep 23, 2026 |
| 75N91026F00020 | Department of Health and Human Services NCI-ARCDCTD-26-0055 - CPTAC BIOSPECIMEN ACQUISITION, PROCESSING, AND DISTRIBUTION | $4.5M | Sep 15, 2026 |
| 75N91026F00027 | Department of Health and Human Services INTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATES | $1.1M | Sep 14, 2026 |
| 75N91026F00024 | Department of Health and Human Services IMPLEMENTATION AND CHARACTERIZATION OF IPSC-DERIVED CELL AND ORGANOID MODELS FOR INTEGRATION INTO NEW APPROACH METHODOLOGIES (NAMS) | $1.3M | Sep 10, 2026 |
| 75N91026F00021 | Department of Health and Human Services 126889 B571 REPLACE CHILLER #3 | $1.3M | Sep 8, 2026 |
Other Leidos Holdings, Inc. entities
UEIs that report the same ultimate parent in SAM.gov. Ownership records can lag acquisitions.
Leidos, Inc.
$13.8BQTC Medical Services Inc
$9.4BLeidos, Inc.
$4.7BLeidos, Inc.
$3.7BLeidos, Inc.
$3.6BLeidos, Inc.
$3.5BDynetics, Inc.
$2.2BLeidos, Inc.
$2.1BLeidos, Inc.
$1.9BLeidos, Inc.
$169.5MPrime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.